CDMO News
EUROAPI Enters Five-Year CDMO Agreement with Priothera
EUROAPI has announced a five-year development and manufacturing agreement with Priothera, a biotechnology company focused on treatments for hematological malignancies and CAR-T cell therapies. This collaboration aims to develop and industrialize the manufacturing process of mocravimod, an innovative oncology molecule,
18 June 2024
Stay ahead of trends and best practices
